In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime-Reference-Cited by-同舟云学术

In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime

Published:2008-11 Issue:11 Volume:52 Page:4209-4210
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Fenoll Asunción¹,Aguilar Lorenzo²,Robledo Olga¹,Giménez María-José²,Granizo Juan-José³,Biek Donald⁴,Tarragó David¹

Affiliation:

1. Spanish National Reference Pneumococcal Laboratory  Instituto de Salud Carlos III  ctra. Majadahonda-Pozuelo Km. 2  28220 Majadahonda, Madrid, Spain

2. Microbiology Department  School of Medicine  Univ. Complutense  Avda. Complutense s/n  28040 Madrid, Spain

3. Grana Datos SL  c/ Demetrio de la Guerra 4  28223 Pozuelo de Alarcón, Madrid, Spain

4. Cerexa, Inc.  1751 Harbor Bay Parkway  Alameda, California 94502

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00712-08

Reference10 articles.

1. Andriesse, G. I., and J. Verhoef. 2006. Nosocomial pneumonia: rationalizing the approach to empirical therapy. Treat. Respir. Med.5:11-30.

2. Bouza, E., V. Pintado, S. Rivera, R. Blazquez, P. Muñoz, E. Cercenado, E. Loza, M. Rodriguez-Creixems, S. Moreno, et al. 2005. Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin. Microbiol. Infect.11:919-924.

3. Canet, J. J., N. Juan, M. Xercavins, N. Freixas, and J. Garau. 2002. Hospital-acquired pneumococcal bacteremia. Clin. Infect. Dis.35:697-702.

4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 7th ed. CLSI document M7-A7. Clinical Laboratory Standards Institute Wayne PA.

5. Clinical and Laboratory Standards Institute/NCCLS. 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI/NCCLS document M100-S18. Clinical and Laboratory Standards Institute Wayne PA.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Community-acquired pneumonia in hospitalized patients: clinical guidelines;Medical Council;2019-12-08

2. Ceftaroline activity on certain respiratory tract and wound infection agents at the minimum inhibitory concentration level;The Journal of Infection in Developing Countries;2015-10-29

3. Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil;Expert Opinion on Drug Metabolism & Toxicology;2014-10-27

4. Left Ventricular Assist Device Endocarditis Caused by Vancomycin-Intermediate Staphylococcus aureus Successfully Treated with Ceftaroline: a Review of the Clinical Case and Overview of Vancomycin Resistance in Staphylococcus aureus;Clinical Microbiology Newsletter;2013-11

5. Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia;Drugs;2013-06-26